Target intelligence / Profile preview

Transforming Growth Factor Beta (TGF-β) Superfamily Ligand (TGF-β Ligand)

Target
TGF-β Ligand
Molecular classification
Secreted Morphogen, Growth Factor, Cytokine, Ligand
01

Overview

The Transforming Growth Factor Beta (TGF-β) superfamily is the largest family of secreted morphogens in animals, comprising highly conserved proteins that regulate a wide array of developmental and physiological processes. Members include TGF-βs, bone morphogenetic proteins (BMPs), activins, growth differentiation factors (GDFs), Nodal, anti-Müllerian hormone (AMH), inhibins, and others. These ligands are synthesized as precursor proteins, proteolytically cleaved to release the mature, active dimer, which then signals through type I and type II serine/threonine kinase receptors to activate Smad transcription factors. Dysregulation is implicated in cancer, developmental disorders, and fibrosis.

Other names
TGF-beta Superfamily LigandsTGFB LigandsBone Morphogenetic ProteinsBMPsActivinsGrowth Differentiation FactorsGDFsNodalAnti-Müllerian HormoneAMHInhibins
02

Mechanism of action

TGF-β superfamily ligands bind to type II receptors, which then recruit and phosphorylate type I receptors. Activated type I receptors then phosphorylate Smad transcription factors, which translocate to the nucleus to regulate gene expression.

03

Biological functions

Embryonic developmentCell proliferationCell differentiationCell motilityCell adhesionApoptosisTissue homeostasisWound healingFibrosisAngiogenesisImmune regulationHormone regulation
04

Disease associations

CancerDevelopmental disordersFibrotic diseasesCachexiaWasting syndromes
05

Safety considerations

Context-dependent effects (promoting or inhibiting cell growth/differentiation)Potential for off-target effects due to broad expression and diverse functionsRisk of promoting fibrosis or tumorigenesis with agonistsRisk of developmental defects with antagonists

Beyond the preview

Go deeper on Transforming Growth Factor Beta (TGF-β) Superfamily Ligand (TGF-β Ligand).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transforming Growth Factor Beta (TGF-β) Superfamily Ligand (TGF-β Ligand).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call